Calmangafodipir May Reduce Chemo-Induced NeuropathyCalmangafodipir May Reduce Chemo-Induced Neuropathy
In colorectal cancer patients treated with the FOLFOX regimen, calmangafodipir reduced the incidence of chemotherapy-induced peripheral neuropathy. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Health | Hematology | Neurology | Peripheral Neuropathy